YKL-40 (chitinase 3-like-1) as a biomarker for psoriasis vulgaris and pustular psoriasis

Journal of Dermatological Science

Volumn 64, Issue 1, 2011, Pages 75-77

  Imai, Yasutomo ^a   Tsuda, Tatsuya ^a   Aochi, Seiko ^b   Futatsugi Yumikura, Shizue ^a   Sakaguchi, Yoshiko ^a   Nakagawa, Noboru ^a   Iwatsuki, Keiji ^b   Yamanishi, Kiyofumi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; YKL 40 PROTEIN;

ADULT; AGED; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS VULGARIS; PUSTULAR PSORIASIS;

ADIPOKINES; ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LECTINS; MALE; MIDDLE AGED; PSORIASIS;

EID: 80052373415     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.06.012     Document Type: Letter

References (6)

1. Takahashi H., Tsuji H., Hashimoto Y., Ishida-Yamamoto A., Iizuka H. Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 2009, 35:645-649.
2. Rathcke C.N., Johansen J.S., Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 2006, 55:53-59.
3. Lee C.G., Hartl D., Lee G.R., Koller B., Matsuura H., Da Silva C.A., et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med 2009, 206:1149-1166.
4. Chupp G.L., Lee C.G., Jarjour N., Shim Y.M., Holm C.T., He S., et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007, 357:2016-2027.
5. Ober C., Tan Z., Sun Y., Possick J.D., Pan L., Nicolae R., et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008, 358:1682-1691.
6. Harvey S., Whaley J., Eberhardt K. The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis. Scand J Rheumatol 2000, 29:391-393.